SCHEMBL16333322

SCHEMBL16333322

COc1nc(NS(C)(=O)=O)ccc1N

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 5/20 0.37
LMNA P02545 3/20 0.37
CYP2C19 P33261 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
SCN9A Q15858 1/20 0.36
PIK3CD O00329 5/20 0.36
PIK3CG P48736 3/20 0.36
PIK3CB P42338 2/20 0.36
BRD4 O60885 1/20 0.36
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
MAPK8 P45983 1/20 0.35
MAPK9 P45984 1/20 0.35
CYP17A1 P05093 2/20 0.35
GAA P10253 1/20 0.34
MAPK1 P28482 1/20 0.34
ESR1 P03372 1/20 0.34
ALDH1A1 P00352 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16887438 0.81 CYP1A2 (0.37) PIK3CALMNACYP2C19SMN1; SMN2SCN9A
SCHEMBL23525752 0.80 CCR4 (0.37) PIK3CALMNAKMT2ASCN9APIK3CD
SCHEMBL30791387 0.80 CCR4 (0.37) PIK3CALMNAKMT2ASCN9APIK3CD
SCHEMBL6679844 0.77 NCF1 (0.39) MAPK8MAPK9ALDH1A1CYP3A4
SCHEMBL10264228 0.77 KMT2A (0.42) LMNASMN1; SMN2MEN1KMT2ASCN9A
SCHEMBL15508008 0.74 KDM4E (0.38) LMNACYP2C19SMN1; SMN2MEN1KMT2A
SCHEMBL31326437 0.72 P4HTM (0.41) SCN9ACA1CA2MAPK8MAPK9
SCHEMBL16741183 0.71 POLB (0.43) SMN1; SMN2MEN1KMT2ABRD4
SCHEMBL19172606 0.69 HCAR3 (0.42) LMNACYP2C19GAAALDH1A1CYP3A4
SCHEMBL7351894 0.68 CA12 (0.46) PIK3CALMNACYP2C19SMN1; SMN2PIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2491023-B1 COUMARIN COMPOUNDS AS RECEPTOR MODULATORS WITH THERAPEUTIC UTILITY ALLERGAN INC (US) 2014-12-31 EP disclosed